Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002074003-25-000001
Filing Date
2025-06-20
Accepted
2025-06-20 17:54:04
Documents
1
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 9456
  Complete submission text file 0002074003-25-000001.txt   11055
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Issuer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address TWO TOWNE SQUARE STE. 810 SOUTHFIELD MI 48076
Business Address
Skaff Michael C (Reporting) CIK: 0002074003 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39796 | Film No.: 251062526